
today's posted documents
- Tax Reform in the 113th Congress: An Overview of Proposals -- Click to view this document
- The U.S. Science and Engineering Workforce: Recent, Current, and Projected Employment, Wages, and Unemployment -- Click to view this document
- The DHS S&T Directorate: Selected Issues for Congress -- Click to view this document
- Sequestration at the Federal Aviation Administration (FAA): Air Traffic Controller Furloughs and Congressional Response -- Click to view this document
- Status of Federal Funding for State Implementation of Health Insurance Exchanges -- Click to view this document
- Pesticide Use and Water Quality: Are the Laws Complementary or in Conflict? -- Click to view this document
- Japan-U.S. Relations: Issues for Congress -- Click to view this document
- Armenia, Azerbaijan, and Georgia: Political Developments and Implications for U.S. Interests -- Click to view this document
Find documents
Drugs, Biologics, and Medical Devices: A Compendium
This Compendium includes a wealth of reports on drugs, biologics and medical devices. The reports included consist of the authority to regulate drug compounding; the law and intellectual property rights of biologics; federal drug discovery and pricing; the FDA’s Safety and Innovation ACT (P.L. 112-114); effects on pharmaceutical innovation and effects of generic brands; infringement and experimental use under the Hatch-Waxman Act. Furthermore, the reauthorization of the Prescription Drug User Fee Act (PDUFA); and how the FDA approves drugs and regulates their safety and effectiveness.
Updated 4-Feb-2013
This package includes following files:
| # | File Name | Document Date | Order ID: | Number of Pages | Price | |
|---|---|---|---|---|---|---|
| 1 |
C-12010 Drugs Biologics and Medical Devices C-12010.pdf
|
Feb 04, 2013 | C12010 | 313 | $79.95 | Add to Cart |


C-12010 Drugs Biologics and Medical Devices C-12010.pdf